US2021000788A1PendingUtilityA1
Nanoparticle isoflavone compositions and methods of making and using the same
Est. expiryNov 15, 2030(~4.3 yrs left)· nominal 20-yr term from priority
A61K 31/353A61K 9/19A61K 9/1652A61K 9/1641A61K 9/1635A61K 9/1623A61K 9/1617A61K 9/1611A61K 31/352A61P 13/08B82Y 5/00A61P 3/06A61P 11/00A61P 43/00A61K 9/10A61P 19/08A61P 15/00A61K 9/0019B82Y 15/00A61K 9/146A61P 5/16A61P 35/00A61K 9/14A61P 17/00A61K 9/0053A61K 9/143A61K 9/145A61P 39/00A61P 1/00A61P 35/02
73
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is directed to formulations of genistein and methods for making and using, the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
Claims
exact text as granted — not AI-modified1 - 64 . (canceled)
65 . A method of preparing a genistein formulation suitable for oral administration, comprising:
combining genistein with a pharmaceutically acceptable suspension medium, the pharmaceutically acceptable suspension medium comprising a water soluble polymer; forming a suspension of the genistein in the pharmaceutically acceptable suspension medium; and isolating a solid dispersion comprising genistein and the water soluble polymer, wherein the solid dispersion is suitable for oral administration.
66 . The method of claim 65 , wherein isolating the solid dispersion comprises at least one of spray drying, lyophilizing, milling, microprecipitation, evaporative precipitation, or antisolvent precipitation.
67 . The method of claim 66 , wherein isolating the solid dispersion comprises spray drying the suspension.
68 . The method of claim 66 , wherein isolating the solid dispersion comprises lyophilizing the suspension.
69 . The method of claim 66 , wherein isolating the solid dispersion comprises milling.
70 . The method of claim 65 , further comprising:
forming particles of the solid dispersion.
71 . The method of claim 65 , further comprising:
packaging the solid dispersion.
72 . The method of claim 65 , wherein the water soluble polymer comprises polyvinylpyrrolidone (PVP).
73 . The method of claim 65 , wherein the suspension further comprises a pharmaceutically acceptable sweetening agent.
74 . The method of claim 65 , wherein the solid dispersion comprises up to 65% w/w genistein.
75 . A method of preparing a genistein formulation suitable for oral administration, comprising:
combining genistein with a pharmaceutically acceptable suspension medium, the pharmaceutically acceptable suspension medium comprising a water soluble polymer comprising polyvinylpyrrolidone; forming a suspension of the genistein in the pharmaceutically acceptable suspension medium; isolating a solid dispersion comprising genistein and the water soluble polymer, wherein the solid dispersion is suitable for oral administration; and packaging the solid dispersion.
76 . The method of claim 75 , wherein isolating the solid dispersion comprises at least one of spray drying, lyophilizing, milling, microprecipitation, evaporative precipitation, or antisolvent precipitation.
77 . The method of claim 76 , wherein isolating the solid dispersion comprises spray drying the suspension.
78 . The method of claim 76 , wherein isolating the solid dispersion comprises lyophilizing the suspension.
79 . The method of claim 76 , wherein isolating the solid dispersion comprises milling.
80 . The method of claim 75 , wherein the solid dispersion comprises up to 65% w/w genistein.
81 . A genistein formulation suitable for oral administration, comprising:
a solid dispersion comprising genistein and a pharmaceutically acceptable suspension medium, the pharmaceutically acceptable suspension medium comprising a water soluble polymer comprising polyvinylpyrrolidone; wherein the solid dispersion is in particulate form.
82 . The formulation of claim 81 , wherein the solid dispersion comprises up to about 65% w/w genistein.
83 . The formulation of claim 81 , wherein the solid dispersion is dehydrated.
84 . The formulation of claim 83 , wherein the solid dispersion is spray dried or lyophilized.Join the waitlist — get patent alerts
Track US2021000788A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.